LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.66 | 771.67 | 1805 | 8978 | 0.2010 | 0.2713 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.88 | 771.67 | 1644 | 9447 | 0.1740 | 0.2328 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.88 | 771.67 | 1836 | 9447 | 0.1943 | 0.2711 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.10 | 771.67 | 1691 | 9800 | 0.1726 | 0.2386 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 67.10 | 771.67 | 1865 | 9800 | 0.1903 | 0.2721 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.32 | 771.67 | 1697 | 10212 | 0.1662 | 0.2355 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 69.32 | 771.67 | 1935 | 10212 | 0.1895 | 0.2798 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.54 | 771.67 | 1744 | 10532 | 0.1656 | 0.2414 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.54 | 771.67 | 1911 | 10532 | 0.1814 | 0.2719 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.76 | 771.67 | 1762 | 10851 | 0.1624 | 0.2417 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.76 | 771.67 | 1883 | 10851 | 0.1735 | 0.2635 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.02 | 771.67 | 1780 | 11106 | 0.1603 | 0.2427 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.02 | 771.67 | 1970 | 11106 | 0.1774 | 0.2758 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.25 | 771.67 | 1809 | 11367 | 0.1591 | 0.2455 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.25 | 771.67 | 1965 | 11367 | 0.1729 | 0.2723 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.48 | 771.67 | 1830 | 11685 | 0.1566 | 0.2464 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.48 | 771.67 | 2004 | 11685 | 0.1715 | 0.2756 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.69 | 771.67 | 1843 | 11974 | 0.1539 | 0.2462 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.69 | 771.67 | 2008 | 11974 | 0.1677 | 0.2735 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.92 | 771.67 | 1875 | 12266 | 0.1529 | 0.2492 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.92 | 771.67 | 2050 | 12266 | 0.1671 | 0.2774 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.14 | 771.67 | 1887 | 12592 | 0.1499 | 0.2485 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.14 | 771.67 | 2163 | 12592 | 0.1718 | 0.2916 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 2.49 | 771.67 | 878 | 867 | 1.0118 | 1.1436 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 2.49 | 771.67 | 1060 | 867 | 1.2215 | 5.5222 | MN20160304_L01 | L05 |